Unlock the Power of Collaborative Innovation

... Xentria, Inc. a biotech company focused on novel biologics and biosimilars, which was established in April 2020. Victoria came to Meitheal from Sagent ... ... Meitheal Pharmaceuticals, Inc.(以下简称“Meitheal”“被许可方”)拟与Xentria签署《许可、开发与商业化协议》(以下简称《许可协议》)，Xentria授予被 ... Meitheal is proud to be partnered with Xentria on XTMAB-16! #xentria #XTMAB16 #pulmonarysarcoidosis. 【商业合作︱生物技术公司Xentria与Meitheal Pharmaceuticals宣布就XTMAB-16达成在北美的独家许可协议】 2023年6月27日，临床阶段生物技术公司Xentria Inc.与Meitheal ... In a deal valued in excess of $600 million, Meitheal will obtain sole rights to market the biologic in North America, with Xentria continuing to ... Popular SearchesXentria IncXentria Corporation LtdXentria Group of Companies LtdXentria ... Xentria and Meitheal Pharmaceuticals Announce Exclusive Licensing ... Tom Shea brings experience from previous roles at Xentria, Meitheal Pharmaceuticals and Sagent Pharmaceuticals. Tom Shea holds a 2009 - 2010 Master Of Business ... Xentria's bid to find a new use for TNF inhibitors has landed it with $45 million in the bank. Building on evidence that Remicade improves ... Xentria's Multi-Year Licensing Agreement with Meitheal. By Martina Bellini. Perkins Coie advised Xentria Inc. on the deal. Xentria Inc., a clinical-stage ... 健友股份(603707)6月27日晚间公告，公司全资子公司香港健友（被许可方代表）及香港健友控股子公司Meitheal（被许可方）拟与Xentria签署许可协议，Xentria授予被许可方 ...